Spiration Raises $18.5 Million

Spiration Inc., a Redmond, Wash.-based maker of medical devices for patients with acute and chronic lung conditions, has raised $18.5 million in Series G funding. Versant Ventures led the round, and was joined by fellow return backers Olympus Medical Systems Corp., New Enterprise Associates, New Leaf Venture Partners, InterWest Partners, Investor Growth Capital and Three Arch Partners. The company has now raised a total of $97 million since its 1999 formation.

 

PRESS RELEASE

 

Spiration, Inc., a developer of novel medical devices designed to benefit patients with acute and chronic conditions of the lung, announced today that the company has raised $18.5 million in a series G round of equity funding from existing investors. Versant Ventures led the financing and Olympus Medical Systems Corp., New Enterprise Associates, New Leaf Venture Partners (Sprout Group), InterWest Partners, Investor Growth Capital and Three Arch Partners also returned as investors. With this financing, the total investment in Spiration